- Home
- PCVX vs BAH Comparison
PCVX vs BAH Comparison
Compare PCVX & BAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | BAH |
|---|---|---|
| Founded | 2013 | 1914 |
| Country | United States | United States |
| Employees | N/A | 35800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.6B |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PCVX | BAH |
|---|---|---|
| Price | $56.59 | $76.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 11 |
| Target Price | $88.25 | ★ $97.00 |
| AVG Volume (30 Days) | 963.3K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 3.09% |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 5.22 |
| Revenue | N/A | ★ $11,980,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.14 |
| P/E Ratio | ★ N/A | $14.90 |
| Revenue Growth | N/A | ★ 12.36 |
| 52 Week Low | $28.09 | $73.93 |
| 52 Week High | $65.00 | $130.91 |
Technical Indicators
Market Signals| Indicator | PCVX | BAH |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 42.99 |
| Support Level | $52.04 | $75.89 |
| Resistance Level | $56.04 | $82.60 |
| Average True Range (ATR) | 2.25 | 2.55 |
| MACD | -0.66 | -0.24 |
| Stochastic Oscillator | 0.00 | 16.88 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.